Welcome to Institute of Genomics
Genoscope Home Page
The CNG is the French national research center which enables a response to scientific questions necessitating high throughput sequencing and genotyping thanks to the development and deployment of innovative integrated technologies. The organization of the CNG enables optimization of genetic and genomic research on human diseases by creating indispensable links between cohort constitution (DNA samples), identification of the responsible genes, and study of the transcriptome and epigenome.
List of the main projects of the Institut de Génomique
The MEDical GENomics excellence laboratory, GENMED, has the objective of promoting the development of research projects on human diseases which are competitive at national and international level. Thus, GENMED evaluates, develops and sets up, in a high-throughput production environment, new-generation technologies and methodologies combined with integrated analysis of genomic data.
GENMED is coordinated by Dr. Jean-François Deleuze, Scientific Director of the Jean Dausset Foundation -CEPH and Director of the National Center for Genotyping (CNG‑IG-CEA). GENMED is copiloted by Prof. François Cambien, INSERM emeritus Research Director. GENMED results from the collaboration of three partners:
GENMED is organized in support of 4 principal focuses:
The shared objectives of GENMED are as follows:
GENMED has financing of € 10.8 million over an 8-year period enabling GENMED to conduct 8 innovative projects in the fields of personalized medicine and translational medicine on a national and international scale. The projects consist in identification of new targets or biomarkers in several diseases such as autism, dilated cardiomyopathy, rare diseases, breast cancer and Alzheimer's disease. The strategy implemented should be deployable for other diseases and thus enable major advances.
In particular, GENMED is to support 'patrimonial' projects such as:
GENMED is also to promote education and training in the field of medical genomics through its partnership with the UPMC and UEVE. With its portfolio and network of partners, GENMED has the ambition of being a significant player in the organization of genomic medicine in France.
Find out more about GENMED: www.genmed.fr
LABEX GENMED - CEA/IG/CNG Launch Meeting
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.